New drug combo for tough lymphoma shows early promise but study halted
NCT ID NCT05626322
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 31 times
Summary
This study looked at a combination of three medicines (maplirpacept, tafasitamab, and lenalidomide) for people with diffuse large B-cell lymphoma that had come back or didn't respond to prior treatment. Participants were not able or willing to have a stem cell transplant or CAR-T therapy. The study was stopped early, and only 6 people took part, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B-CELL LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Dong-A University Hospital
Busan, Pusan-kwangyǒkshi, 49201, South Korea
-
Lifespan Cancer Institute
Providence, Rhode Island, 02903, United States
-
Mary Bird Perkins Cancer Center
Baton Rouge, Louisiana, 70809, United States
-
Seoul National University Hospital
Seoul, Seoul-teukbyeolsi [seoul], 03080, South Korea
-
The Miriam Hospital
Providence, Rhode Island, 02906, United States
-
University of Michigan
Ann Arbor, Michigan, 48109, United States
-
Yamagata University Hospital
Yamagata, 990-9585, Japan
Conditions
Explore the condition pages connected to this study.